---
title: "Psych News Alert: FDA Approves Caplyta to Treat Schizophrenia in Adults"
description: The Food and Drug Administration (FDA) this week approved Caplyta (lumateperone), an oral atypical antipsychotic medication to treat schi...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/FDA_NewLogo-Jun-24-2025-04-20-36-2756-PM.jpg
---

 12/26/19 12:00 AM

# FDA Approves Caplyta to Treat Schizophrenia in Adults

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2019/12/fda-approves-caplyta-to-treat.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2019/12/fda-approves-caplyta-to-treat.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2019/12/fda-approves-caplyta-to-treat.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2019/12/fda-approves-caplyta-to-treat.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2019/12/fda-approves-caplyta-to-treat.html)

| ![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/FDA_NewLogo-Jun-24-2025-04-20-35-4029-PM.jpg?width=200&height=200&name=FDA_NewLogo-Jun-24-2025-04-20-35-4029-PM.jpg) |  |
| --- | --- |

The Food and Drug Administration (FDA) this week approved Caplyta (lumateperone), an oral atypical antipsychotic medication to treat schizophrenia in adults.

“Schizophrenia is a complex disease that severely impacts patients and their families,” Jeffrey A. Lieberman, M.D., the Lawrence C. Kolb Professor and Chairman of Psychiatry at Columbia University, said in a [statement](https://ir.intracellulartherapies.com/news-releases/news-release-details/fda-approves-intra-cellular-therapies-novel-antipsychotic). “Effective treatment provided in a timely fashion can be game-changing for people living with schizophrenia. The efficacy and safety profile of Caplyta … offers health care providers an important new option for treating people living with schizophrenia.”

The [approval](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209500) of Caplyta was supported by two four-week, placebo-controlled trials involving a total of 785 adults with schizophrenia. In both trials, patients receiving 42 mg lumateperone achieved a statistically significant reduction in the Positive and Negative Syndrome Scale (PANSS) score at the end of 28 days compared with placebo. In the first trial, the PANSS score decreased 13.2 points in the treatment group compared with 7.4 points in the placebo group. In the second trial, the PANSS score decreased 14.5 points in the treatment group compared with 10.3 points in the placebo group. The most common adverse reactions were sleepiness/sedation and dry mouth.

The labeling for Caplyta includes a boxed warning noting that older patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death. Caplyta is not approved for the treatment of patients with dementia-related psychosis.

According to Intra-Cellular Therapies, the company will launch Caplyta in the next few months.

For related information, see the *American Journal of Psychiatry* article “[Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia](https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.19010034).”

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/Twitter_Bird-Jun-24-2025-04-23-22-1740-PM.png?width=21&height=17&name=Twitter_Bird-Jun-24-2025-04-23-22-1740-PM.png)](https://alert.psychnews.org/hubfs/Imported_Blog_Media/Twitter_Bird-Jun-24-2025-04-23-22-1740-PM.png) 

**[Follow *Psychiatric News* on Twitter!](https://twitter.com/PsychiatricNews)

And check out the new [*Psychiatric News Brief*](http://alexapn.apapublishing.libsynpro.com/) on Alexa-enabled devices.**

[schizophrenia](https://alert.psychnews.org/tag/schizophrenia), [lumateperone](https://alert.psychnews.org/tag/lumateperone), [Food and Drug Administration](https://alert.psychnews.org/tag/food-and-drug-administration), [Positive and Negative Syndrome Scale](https://alert.psychnews.org/tag/positive-and-negative-syndrome-scale), [Jeffrey A. Lieberman](https://alert.psychnews.org/tag/jeffrey-a-lieberman), [Intra-Cellular Therapies](https://alert.psychnews.org/tag/intra-cellular-therapies), [Caplyta](https://alert.psychnews.org/tag/caplyta)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/shutterstock_66798091-Jun-24-2025-06-21-29-4046-PM.jpg?height=200&name=shutterstock_66798091-Jun-24-2025-06-21-29-4046-PM.jpg) ](https://alert.psychnews.org/2011/10/recovery-from-psychotic-disorders-is.html)

[schizophrenia](https://alert.psychnews.org/tag/schizophrenia), [recovery](https://alert.psychnews.org/tag/recovery), [psychosis](https://alert.psychnews.org/tag/psychosis)

## [Recovery From Psychotic Disorders Is Real](https://alert.psychnews.org/2011/10/recovery-from-psychotic-disorders-is.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 10/24/11 12:00 AM

[ Read more ](https://alert.psychnews.org/2011/10/recovery-from-psychotic-disorders-is.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/lieberman-Jun-24-2025-07-22-05-0430-PM.jpg?height=200&name=lieberman-Jun-24-2025-07-22-05-0430-PM.jpg) ](https://alert.psychnews.org/2013/08/early-detection-of-schizophrenia-time.html)

[schizophrenia](https://alert.psychnews.org/tag/schizophrenia), [Jeffrey Lieberman](https://alert.psychnews.org/tag/jeffrey-lieberman), [early onset schizophrenia](https://alert.psychnews.org/tag/early-onset-schizophrenia)

## [Early Detection of Schizophrenia: The Time Is Now](https://alert.psychnews.org/2013/08/early-detection-of-schizophrenia-time.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 8/15/13 12:00 AM

APA President Jeffrey Lieberman, M.D., is using the Psychiatric News Alert as a forum to reach APA...

[ Read more ](https://alert.psychnews.org/2013/08/early-detection-of-schizophrenia-time.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/lieberman-Jun-24-2025-07-43-52-1506-PM.jpg?height=200&name=lieberman-Jun-24-2025-07-43-52-1506-PM.jpg) ](https://alert.psychnews.org/2013/01/oscar-nominated-film-could-help-those.html)

[Jeffrey Lieberman](https://alert.psychnews.org/tag/jeffrey-lieberman), [M.D.](https://alert.psychnews.org/tag/m-d-)

## [Oscar-Nominated Film Could Help Those With Mental Illness](https://alert.psychnews.org/2013/01/oscar-nominated-film-could-help-those.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 1/31/13 12:00 AM

"It has been a long time since a Hollywood movie actually seemed like it could help people...

[ Read more ](https://alert.psychnews.org/2013/01/oscar-nominated-film-could-help-those.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T16:23:53.909Z",
  "datePublished" : "2019-12-26T05:00:00.000Z",
  "headline" : "Psych News Alert: FDA Approves Caplyta to Treat Schizophrenia in Adults",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/FDA_NewLogo-Jun-24-2025-04-20-36-2756-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2019/12/fda-approves-caplyta-to-treat.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```